B of A Securities upgrades Ambev (NYSE:ABEV) from Underperform to Neutral.
B of A Securities Upgrades Ambev to Neutral
B of A Securities upgrades Ambev (NYSE:ABEV) from Underperform to Neutral.
Related Posts
Alimera Announces Pricing, Reimbursement Of Uveitis Indication Granted For ILUVIEN In France
Alimera Sciences, Inc. (NASDAQ:ALIM) ("Alimera"), a global pharmaceutical company whose mission is to be invaluable to patients, physicians and partners concerned with retinal health and maintaining
Piper Sandler Maintains Overweight on Howard Hughes, Raises Price Target to $120
Piper Sandler analyst Alexander Goldfarb maintains Howard Hughes (NYSE:HHC) with a Overweight and raises the price target from $115 to $120.
‘PagSeguro and StoneCo– Not “seguro” after all’ -Report From Short Seller Viceroy Research
https://viceroyresearch.org/2021/10/27/pagseguro-and-stoneco-not-seguro-after-all/